Tandem Diabetes Care (TNDM) Stock Forecast & Price Prediction

Estimation of the future price movement of Tandem Diabetes Care stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target


Current $33.50

Concensus $102.50


Low $36.00

Median $111.00

High $160.00

Based on analysts projections #TNDM is expected to experience a positive growth trajectory over the next year.

The current average TNDM price target, as estimated by these analysts, is $102.50.

The predictions for the future TNDM stock price range from a low of $36.00 to a high of $160.00, highlighting the variability of market expectations for TNDM.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

TNDM stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted
Kenneth Leon
CFRA
April 11, 2024 Buy 36.00 33.87
Mathew Blackman
Stifel Nicolaus
March 25, 2024 Buy 37.00 30.10
Jayson Bedford
Raymond James
August 17, 2022 Buy 92.00 52.81
Larry Biegelsen
Wells Fargo
August 9, 2022 Buy 49.00 60.10
Matt O'Brien
Piper Sandler
August 4, 2022 Buy 80.00 68.97
Matt O'Brien
Piper Sandler
May 5, 2022 Buy 120.00 94.43
Travis Steed
Bank of America Securities
March 3, 2022 Buy 130.00 112.96
Josh Jennings
Cowen & Co.
November 4, 2021 Buy 141.00 132.51
Ravi Misra
Berenberg Bank
November 4, 2021 Buy 147.00 132.51
Alexander Nowak
Craig-Hallum
August 5, 2021 Buy 153.00 109.97
Matthew Taylor
UBS
August 5, 2021 Buy 160.00 109.97

Tandem Diabetes Care (TNDM) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if Tandem Diabetes Care is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.

Neutral

Financial Scores

Updated on: 13/04/2024

Altman Z-Score: 1.6

Piotroski Score: 3.0

ESG Score

Updated on: 13/04/2024

Environmental: 54.2

Social: 60.6

Governance: 59.5

Financial Health

Updated on: 13/04/2024

DCF: Sell

ROE: Sell

ROA: Neutral

Debt to equity ratio: Strong Buy

Price to earnings ratio: Strong Sell

Price to book ratio: Strong Buy

TNDM Discounted Cash Flow

Updated on: 13/04/2024

$-0.391
Discounted Cash Flow Value


$33.500
Current Price

TNDM Revenues by Segment

Updated on: 13/04/2024

Connect Hosting Service
$20,000.00

Revenue from Contract with Customer, Excluding Assessed Tax

TNDM Revenues by Region

Updated on: 13/04/2024

Non-US
$1,928,400.00
UNITED STATES
$5,548,780.00

TNDM Notes Due

Updated on: 13/04/2024

CIKExchangeTitle

There are no data to display

Tandem Diabetes Care (TNDM) Social Sentiments

Monitoring bullish and bearish sentiments towards Tandem Diabetes Care on Twitter and Stocktwits could help to forecast an upward or downward trend in Tandem Diabetes Care stock price.

No social results for TNDM

Tandem Diabetes Care: A Promising Medical Device Company with Strong Stock Forecast Potential

Tandem Diabetes Care - A Medical Device Company with a Promising Stock Forecast Tandem Diabetes Care (Ticker: TNDM) is an innovative medical device company that focuses on providing comprehensive diabetes management solutions to people with insulin-dependent diabetes. The company's core product line includes insulin pumps, continuous glucose monitoring systems, and other related products that enable diabetic patients to manage their... Read more

Predicting the Future of Medical Devices Stock Market: Analyzing Tandem Diabetes Care's Potential Growth

The Medical Devices stock market sector refers to a group of companies that develop, manufacture and distribute medical devices for healthcare purposes. These devices range from simple tools like thermometers to more advanced equipment like pacemakers and insulin pumps. One of the leading companies in this sector is Tandem Diabetes Care, who provides a revolutionary insulin delivery system. As people... Read more